Celltrion Healthcare, 626,565 Shares Sold Net by Foreigners in Last 5 Days... Stock Price at 124,900 KRW (-3.33%)

As of 2:31 PM on the 8th, Celltrion Healthcare is trading at 124,900 KRW, down 3.33% from the previous day. The trading volume is 612,413 shares, which is 66.92% of the previous day's volume. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

On March 5th, Minjeong Seon, a researcher at Hana Financial Investment, stated, "If the effect of new product launches appears from the third quarter, the second quarter could be somewhat risky. Since the base in the second quarter of last year was high, sales in the second quarter of this year may decrease compared to the previous year due to a reverse base effect. The hidden card that can offset this sales decline is Rekkeulonaju. Rekkeulonaju is also likely to be marketed in Europe in the second quarter. If so, it is expected to fill the gap in Celltrion Healthcare's second quarter." She set the target price for Celltrion Healthcare at 175,000 KRW.

Over the past five days, individual investors have net purchased 556,647 shares of Celltrion Healthcare, while foreigners and institutions have net sold 626,565 shares and net purchased 73,524 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.